Key result
MicroRNAs play an important role in the pathogenesis of diabetic neuropathy and hold promise as both biomarkers and therapeutic targets, particularly when packaged within extracellular vesicles.
Why the study?
The exact pathophysiological mechanisms of diabetic neuropathy remain unclear, and the roles of microRNAs as biomarkers and potential therapeutic targets warrant review.
Design
Review
Authors
Loading...
Supports microRNA research in diabetic neuropathy; leaves open clinical translation as biomarkers or therapies pending validation.
This review highlights the potential of miRNAs, particularly when packaged in extracellular vesicles, as novel biomarkers and therapeutic targets for diabetic neuropathy.
Fan et al. (2020) conducted a review in Diabetic Neuropathy. microRNAs was evaluated. MicroRNAs play an important role in the pathogenesis of diabetic neuropathy and hold promise as both biomarkers and therapeutic targets, particularly when packaged within extracellular vesicles.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: